EP Patent

EP1293209A1 — Oral pharmaceutical dosage forms with reduced potential for drug abuse

Assigned to Rohm and Haas Co · Expires 2003-03-19 · 23y expired

What this patent protects

Solid oral dosage forms of controlled substances are described that have reduced potential for abuse by inhalation, mastication, and injection .

USPTO Abstract

Solid oral dosage forms of controlled substances are described that have reduced potential for abuse by inhalation, mastication, and injection .

Drugs covered by this patent

carvedilol-phosphate (CARVEDILOL PHOSPHATE)

Patent Metadata

Patent number: EP1293209A1
Jurisdiction: EP
Classification: —
Expires: 2003-03-19
Drug substance claim: No
Drug product claim: No
Assignee: Rohm and Haas Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.